The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An open-label, multicenter, phase Ib/II study of the ATR inhibitor SC0245 in combination with irinotecan in patients with relapsed and refractory extensive stage small cell lung cancer (ES-SCLC).
 
Yongfeng Yu
No Relationships to Disclose
 
Dingzhi Huang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Chun-lai Li
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Sheng Wang
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Hai-jun Guo
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Rong Su
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Li-qin Zhang
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Shi-chang Li
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Yi-wei Wang
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
Leadership - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Yong-Jiang Hei
Employment - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
Leadership - 4.Biocity Biopharmaceutics Co,.Ltd, Wuxi, China.
 
Shun Lu
No Relationships to Disclose